You are here

A STAINING METHOD FOR ELECTROPHORETICALLY SEPARATED CLOTTINGFACTORS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 13936
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1990
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
4291 Lantern Dr
Winston-salem, NC 27106
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 George J Doellgast
 (919) 777-3624
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THIS PROJECT WILL DEVELOP AN ELECTROPHORETIC STAINING METHOD FOR CLOTTING FACTORS. THE METHOD MEASURES COAGULATION USING A COLORIMETRIC SYSTEM KNOWN AS ENZYME-LINKED COAGULATION ASSAY (ELCA). ELCA IS BASED ON THE SIMULTANEOUS CONVERSION OF SOLID-PHASE-ASSOCIATED FIBRINOGEN AND ENZYME-LABELED FIBRINOGEN IN SOLUTION BY THROMBIN, WHICH IS GENERATED IN OR ADDED TO THE SOLID-PHASE-ASSOCIATED MIXTURE. IN THIS STUDY, NITROCELLULOSE MEMBRANES WILL EITHER BIND THE CLOTTING FACTOR BY BLOTTING TRANSFER OR BE USED AS A SUBSTRATE VEHICLE FOR IDENTIFICATION OF THE LOCATION OF BANDS FROM ELECTROPHEROGRAMS; THE MEMBRANES WILL BE FIBRINOGEN COATED AND BLOCKED WITH CASEIN. ELCA ASSAYS WILLBE PERFORMED BY ADDING SUBSTRATE CONTAINING ALL FACTORS NEEDED FOR ASSAY OF A PARTICULAR FACTOR INCLUDING LABELED FIBRINOGEN. TWO PROTOCOLS FOR IDENTIFICATION OF THE SEPARATED COMPONENTSWILL BE USED. IN THE FIRST, THE SOLID PHASE WILL HAVE BOUND TO IT CLOTTING FACTORS TRANSFERRED FROM NONDENATURING ELECTROPHEROGRAMS; IN THE SECOND, THE SOLID PHASE WILL BE OVERLAID DIRECTLY ONTO POLYACRYLAMIDE GELS WITH SEPARATED CLOTTING FACTORS. THIS WILL PERMIT THE FUNCTIONAL IDENTIFICATION OF ACTIVE CLOTTING FACTORS ON ELECTROPHEROGRAMS. THIS WILL BE OF USE IN THE IDENTIFICATION OF GENETIC VARIANTS, ACTIVE AND ACTIVATED CLOTTING FACTORS IN PLASMA SAMPLES, AND PARTIALLY CARBOXYLATED CLOTTING FACTORS FROM COUMADIN-TREATED PATIENTS.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government